-
Innovation Ranking
NewInnovation Ranking – Telefonaktiebolaget LM Ericsson
Telefonaktiebolaget LM Ericsson (Ericsson) is a provider of integrated telecommunications technology and services. It offers services, software and infrastructure in the areas of mobility, broadband and cloud enabling telecom operators and other businesses to enhance operational efficiency. The company also offers its products and services across networks, digital services, managed services and emerging business. Ericsson’s primary offering includes network infrastructure for mobile and fixed communication such as 2G, 3G and 4G radio networks, and IP core and transport networks. The...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LM-24C5 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LM-24C5 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LM-24C5 in Solid Tumor Drug Details: LM-24C5 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LM-302 in Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LM-302 in Ovarian Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LM-302 in Ovarian Cancer Drug Details: LM-302 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LM-302 in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LM-302 in Colorectal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LM-302 in Colorectal Cancer Drug Details: LM-302 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LM-302 in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LM-302 in Pancreatic Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LM-302 in Pancreatic Cancer Drug Details: LM-302 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LM-302 in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LM-302 in Gastric Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LM-302 in Gastric Cancer Drug Details: LM-302 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LM-302 in Esophageal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LM-302 in Esophageal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LM-302 in Esophageal Cancer Drug Details: LM-302 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LM-302 in Adenocarcinoma Of The Gastroesophageal Junction
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LM-302 in Adenocarcinoma Of The Gastroesophageal Junction report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LM-302 in Adenocarcinoma Of The Gastroesophageal Junction Drug Details:...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – LM-302 in Bile Duct Cancer (Cholangiocarcinoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LM-302 in Bile Duct Cancer (Cholangiocarcinoma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LM-302 in Bile Duct Cancer (Cholangiocarcinoma) Drug Details: LM-302 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LM-108 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LM-108 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LM-108 in Solid Tumor Drug Details: LM-108 is under development for...